What is prematurity?
What is important to know prior to the birth of a premature infant?
What is the chance of survival for a premature infant?
What is the delivery room management of the premature infant?
What problems can be expected in the nursery?
What needs to happen for my baby to go home?
What is the outcome for survivors of the intensive care nursery?
by Adam A. Rosenberg, M.D.
Director of Newborn Services at University Hospital
Professor of Pediatrics at the University of Colorado School of Medicine
Any infant born at less than 37 weeks gestation is by definition "premature." Most
infants born at 35 to 37 weeks gestation are relatively healthy, and they often
have only brief hospital stays in normal newborn nurseries. The problems associated
with premature infants occur with greater frequency in those of lower gestational
age at birth, typically less than 35 weeks gestation.
Some treatments may be used in mothers who are at risk of having their baby early.
Anyone who has had a previous preterm infant is at a "high risk" of having another
preterm infant. Therefore, prenatal care should be sought with a caregiver who is
up to date and comfortable with the management of a mother who is at risk for a
When a mother is in preterm labor, she should be admitted to the hospital and placed
on drugs to slow the progress of labor. Although these drugs will not delay delivery
for very long in many cases, they often allow enough time to receive a full course
of steroids (betamethasone or dexamethasone) to accelerate the maturation of the
fetus. Steroids have been shown to decrease the rate of death of preterm infants,
as well as decrease the rate of lung, intestinal, and brain complications.
When there is a risk of delivering a baby early, it is appropriate to ask if the
nursery at the hospital is able to take care of a preterm baby. If not-if it is
safe for the mother and fetus-they should be transferred to a facility that is capable
of caring for the baby after birth. In addition, an expectant mother should talk
with the hospital staff members who will care for the baby after birth. Issues to
discuss include a review of the problems associated with prematurity, chances of
survival, and the anticipated long-term outcome.
The survival of premature infants is determined by gestational age at delivery and
birth weight. Infants born after 28 weeks gestation and 1,000 grams, or 3 pounds
3 ounces (454 grams equals 1 pound), have more than a 90% chance of survival. The
rate of survival at 27 weeks and 900 grams is 80% to 85%, at 26 weeks and 800 grams
is 75% to 80%, and at 25 weeks and 700 grams is 60%. Rates of survival drop off
rapidly at less than 25 weeks, and they vary quite a bit among different nurseries.
The long-term outcome also is dependent on gestational age and birth weight. For
babies of 26 to 32 weeks gestation, the rate of severe neurodevelopmental problems
among survivors is about 10%; at 23 to 26 weeks, the rate increases gradually to
25% of survivors. Other long-term complications, including lung problems, vision
disturbances, and hearing loss, are more common in babies of lower gestational age
Staff members who are experienced in the management of premature infants should
be present in the delivery room. The infant must be kept warm; provided with adequate
oxygen; and helped with breathing, if necessary. Most infants who weigh less than
1,000 grams at birth will require a breathing tube in their airway.
Preterm infants are not able to maintain their body temperature without an external
heat source. Initially, heat will be provided with an overhead warmer that responds
to the baby's temperature and provides adequate warmth to maintain a normal body
temperature. The warmer provides easy access to the baby for necessary cares during
the early, "unstable" period. When more stable, the baby will be moved into an incubator
to maintain a warm environment. Most infants are able to move into an open crib
at a weight of approximately 1,800 grams.
Initially, premature infants are given all the necessary fluid, calories, protein,
sugar, and fat in their veins. When their condition stabilizes, a feeding tube into
their stomachs can start. The amount of feeds starts at a very low level, and it
is advanced slowly over 3 to 7 days to "full" feeds. At this point, the infant no
longer needs fluids or nutrition into their veins. Once full feeds are achieved,
anticipated rates of weight gain are 10 to 25 grams per day. Breast milk is the
food of choice, but formulas developed for preterm infants are an acceptable substitute.
A baby will be able to begin "nipple" feeding from a bottle at about 33 to 34 weeks
All babies in intensive care nurseries have their heart rates, breathing, and, in
some cases, blood pressure monitored continuously. Blood oxygen also can be monitored
with a pulse oximeter in infants with lung and heart problems. A pulse oximeter
uses a light source, wrapped around the infant's foot or hand, to measure the amount
of oxygen carried by the hemoglobin in the red blood cells. At the start, a sick
baby will usually have an indwelling tube in an artery (usually the umbilical artery
in the cord that was connected to the placenta in the uterus) to sample blood for
tests without having to draw blood from the infant. A tube also may be placed in
the umbilical vein to give fluids and nutrition. These tubes are usually kept in
the infant for 3 to 10 days depending on how sick they are.
Hyaline membrane disease (HMD) or respiratory distress syndrome (RDS). By 24 weeks
gestation, there is adequate surface for gas exchange (bringing oxygen to the blood
and removing carbon dioxide) in the lung; however, a necessary element for survival
is missing. The natural tendency of a lung is to collapse when a person breathes
out. Once collapsed, it is very difficult to reopen the lung. A chemical called
surfactant is produced in the lungs to lower surface tension as the lungs get smaller
during exhalation. This chemical prevents a total collapse of the lungs and allows
easy re-expansion with inhalation.
Preterm babies have little or no surfactant in their lungs, and they would die from
respiratory failure without intervention. The frequency of surfactant deficiency
ranges from nearly 100% at 24 weeks gestation, to 60% at 28 weeks and 25% at 32
weeks. To treat this condition, babies are given surfactant substitutes through
their breathing tubes into the lungs and to help them breathe with breathing machines
called ventilators. Depending on their gestation at birth, premature infants will
remain on the ventilator from a few days to up to about 6 weeks.
When babies are ready to come off the ventilator, they are "extubated" (removal
of the breathing tube) to either nasal CPAP (provides low pressure through a device
placed in the nose to help keep the lungs expanded) or to a bubble with extra oxygen
placed over the head. Ultimately, supplemental oxygen can be delivered with a small
hose under the nose called a nasal cannula.
Apnea and bradycardia (A&B spells). At the time of birth, preterm infants have an
immature respiratory drive. This results in spells when they "forget" to breathe
(apnea). If these spells are long enough, they result in a decrease in blood oxygen
and then a slowing of the heart rate (bradycardia). Sometimes, these episodes resolve
themselves, while, in other cases, the infants need to be stimulated to restart
breathing. If the spells are bad enough or occur with a frequency of more than 6
to 10 times per day, they can be treated medically with caffeine (like in coffee)
In most infants, this is successful; however, if this treatment fails, it is sometimes
necessary to place the infant back on nasal CPAP or the ventilator. Infants born
beyond 28 weeks gestation generally outgrow these spells by 37 weeks post conception.
In infants born at lower gestational ages, the spells may last longer.
Chronic lung disease (CLD) or bronchopulmonary dysplasia (BPD). The combination
of prematurity, oxygen exposure, and mechanical ventilation can result in lung injury
to preterm babies. The consequence of this lung injury is chronic lung disease.
CLD can prolong ventilator courses in small preterm infants (less than 1,200 grams)
and result in a long-term oxygen need that can sometimes extend to home care. The
frequency of this complication is greatest in the least mature infants, and, in
those infants less than 26 weeks gestation at birth, it can occur in over 75% of
cases. However, the lungs still generate new gas exchange surface until adolescence
so the vast majority of infants outgrow this problem.
Patent ductus arteriosus (PDA)
The major heart-related problem in premature infants is PDA. The ductus is a structure
that is present in a fetus connecting the main blood vessel that goes to the lungs
from the heart to the main blood vessel that goes to the rest of the body. In the
fetus, very little blood goes to the lungs because the fetus does not breathe air.
The ductus allows the majority of the blood that is headed from the heart to the
lungs to cross to the circulation to the body, bypassing the lungs. At birth, it
is supposed to close.
In preterm babies, this closure may not occur. After birth, if this vessel is open,
too much blood ends up going to the lungs, making it harder for an infant to breathe
or to be ventilated. To close this blood vessel, the medication indomethacin is
used. This works over 75% of the time; however, if it fails, a surgical closure
is needed. Fortunately, it is a brief procedure that can be done at the bedside
with almost uniformly good results.
Necrotizing enterocolitis (NEC)
The most important intestinal complication in preterm babies is NEC. This disease
is the result of periods of low blood flow to the intestine, intestinal immaturity,
and infection. When a baby develops this problem, they cannot be fed into the intestine
and require 10 to 21 days of nutrition in their veins. In addition, a large tube
is placed in the stomach to keep air out, and antibiotics are given. Many of the
cases respond to this treatment, but, in some cases, surgery is needed to remove
parts of the intestine that have died.
Intraventricular hemorrhage (IVH)
The internal structures of the brain in a preterm infant are at risk for hemorrhage.
The bleeding is usually the result of a previous period of low blood flow, and occurs
in the first four days of life. Diagnosis of the bleeding is performed with bedside
ultrasound exams. The degree of bleeding is graded from 1 to 4. Grade 1 and 2 bleeds
are small, and they do not increase the infant's risk of neurodevelopmental abnormalities,
while 33% of the babies with grade 3 and 4 bleeds will suffer severe neurologic
injury, and another 33% will suffer lesser deficits. The final neurologic complication
in preterm babies is injury to the motor tracts in the brain called periventricular
leukomalacia (PVL), which causes cerebral palsy-a movement disorder with spasms
that can impair the ability to walk.
Retinopathy of prematurity
The retina of the preterm infant is not fully "vascularized"(i.e., the blood vessels
are not fully developed) at birth. The infant is at risk for a process called ROP,
which, in its worst form, can lead to detachment of the retina and blindness. In
babies born at less than 28 weeks or 1,500 grams, an ophthalmologist will perform
a screening exam at 6 weeks of age.
Follow-up exams will then be performed until any ROP resolves, and the retina is
fully vascularized. ROP is graded from 1 to 5 for severity. The process resolves
spontaneously in most infants, but those infants who reach an advanced stage 3 of
disease are at a high risk for detachment of the retina. These infants require treatment
with laser therapy, which often can save the vision in the affected eye(s).
Anemia of prematurity
Because of blood sampling for tests and conditions that cause blood loss, such as
inventricular hemorrhage, many preterm babies will require red blood cell transfusions.
To decrease the number of transfusions given and to minimize donor exposure, preterm
babies can be treated with the hormone erythropoietin, which stimulates red blood
cell production in the body.
Virtually all preterm babies will develop jaundice. Jaundice is caused by an accumulation
of the yellow pigment "bilirubin," which is the breakdown product of hemoglobin
from the red blood cells. A preterm infant cannot effectively clear the bilirubin
in the liver. If too much bilirubin accumulates in the blood, it can cause brain
damage. To help these infants in clearing the bilirubin to prevent brain damage,
they are placed under phototherapy ("bilirubin lights").
Some preterm deliveries are the result of an infection in the uterus, which also
can lead to an infection in the baby. In addition, infants in the intensive care
nursery are at an increased risk for infection due to indwelling lines and tubes,
as well as a compromised immune ("infection fighting") system. Thus, the risk of
infection is high. If there is concern that an infant might be infected or there
is a proven infection, the infant is treated with antibiotics-an event that is likely
to occur more than once during the nursery stay.
Most preterm infants are ready for discharge at or a few weeks before their due
date. The criteria for discharge include the ability to maintain body temperature
in a crib, adequate oral intake to sustain consistent growth, and resolution of
apneic and bradycardic spells. Occasionally, infants who are otherwise doing well
may be sent home on partial tube feedings.
In addition, if A&B spells are not completely resolved, but are not felt to be life
threatening, some physicians will send a baby home on a heart monitor. If an infant
needs supplemental oxygen at discharge, a test needs to be performed prior to going
home to be sure if the oxygen were to fall off that the blood oxygen does not drop
to dangerously low levels.
Neurodevelopmental handicaps may occur in survivors of the intensive care nursery.
These handicaps include cerebral palsy, which can be severe enough to prevent a
child from walking, and cognitive deficits, which can be severe enough to prevent
a child from learning to talk or read. Fortunately, deficits this severe occur in
the minority of survivors, but others may have lesser deficits that cause delayed
motor development, learning disabilities, and behavioral disorders, such as attention
deficit disorder (hyperactivity).
The rates of abnormalities are higher in babies of lower gestational age at birth,
particularly those born at 25 weeks or less. Although ROP rarely causes blindness,
vision problems may still occur. The frequency of hearing loss is increased compared
to term infants. The consequences of chronic lung disease are an increased rate
of hospital readmission during the first two years of life, a continued oxygen need,
and an increased incidence of asthma-like symptoms.
Finally, preterm infants are at an increased risk for poor weight gain, and they
may require nutritional supplements or special formulas. Most premature infants
who "graduate" from an intensive care nursery do quite well; however, coordinated
follow-up to address all of their needs is of paramount importance.
Fanaroff A.A., Martin R.J. (editors): Neonatal-Perinatal Medicine. Diseases of the Fetus and Infant, 6th ed., Mosby, 1997.
Zaichkin J.: Newborn Intensive Care. What Every Parent Needs to Know. NICU Ink, 1996.
About the Author
Dr. Rosenberg graduated from Vanderbilt Medical School in 1976. His Pediatric Residency was at the University of Colorado and his Neonatal Fellowship was fulfilled at Johns Hopkins University. He is the Director of Newborn Services at University Hospital in Denver and Professor of Pediatrics at the University of Colorado School of Medicine.
His professional interests include newborn brain injury and long-term follow up of high-risk newborns. Some of his personal interests include tennis, skiing and youth sports programs.
Copyright 2012 Adam A. Rosenberg, M.D., All Rights Reserved
The information contained in these topics is not intended nor implied to be a substitute for professional medical advice, it is provided for educational purposes only. You assume full responsibility for how you choose to use this information.
Always seek the advice of your physician or other qualified healthcare provider before starting any new treatment or discontinuing an existing treatment. Talk with your healthcare provider about any questions you may have regarding a medical condition. Nothing contained in these topics is intended to be used for medical diagnosis or treatment.
If you think that you are having a medical emergency,
call 911 or the number for the local emergency ambulance service NOW!
And when in doubt, call your doctor NOW
or go to the closest emergency department.
By using this website, you accept the information provided herein "AS IS." Neither RemedyConnect nor the providers of the information contained herein will have any liability to you arising out of your use of the information contained herein or make any express or implied warranty regarding the accuracy, content, completeness, reliability, or efficacy of the information contained within this website.
RemedyConnect, Inc. has created this privacy statement in order to demonstrate our firm commitment to your privacy. The following discloses our information gathering and dissemination practices for this website: http://www.remedyconnect.com.
Acquisition of Information through PMD
We do not acquire any more information about website visitors than is required by law or is otherwise necessary to provide a high level of service efficiently and securely. Our site's registration form requires users to give us contact information (e.g., their name and e-mail address) and demographic information (e.g., children's birth months, but not birth dates). We use customer contact information from the registration form to (1) send the user pertinent medical and parenting information and (2) allow your local health provider lists of who is registering on that provider's site as a parent/guardian, staff member, doctor, or visitor. Users may opt-out of receiving future mailings; see the choice/opt-out section below.
We use your IP address to help diagnose problems with our server and to administer our Website. Your IP address is used to help identify you and to gather broad demographic information.
Demographic and profile data is also collected at our site. We may use this data to tailor the visitor's experience at our site, showing them content that we think they might be interested in, and displaying the content according to their preferences.
Our site may use order forms to allow users to request information, products, and services.
Your Doctor's Right to Privacy
We will respect your doctor's right to privacy. A doctor typically does not give his/her e-mail address to the parents/guardians of patients. We will not provide the e-mail addresses of doctor(s) in the local practice to users of their site without the doctor(s)' permission. Their site is restricted to use by whomever they wish, and they may deny access to their site to one or more prior users. In unusual cases, doctors may change their private site's access code and arrange for us to e-mail the new access code to approved users.
This site contains links to other sites. RemedyConnect.com is not responsible for the privacy practices or the content of such Websites. See Disclaimers.
Disclosure to Third Parties
We will provide individually-identifiable information about website users to third parties only if we are compelled to do so by order of a duly-empowered governmental authority, we have the express permission of the visitor, or it is necessary to process transactions and provide you services from our affiliates: Live Agent Answering Service, Digital Answering Service, Medical Answering Service and Pediatric Answering Service.
Privacy and Our Business Partners
This site may make chat rooms, forums, message boards, and/or news groups available to its users. Please remember that any information that is disclosed in these areas becomes public information and you should exercise caution when deciding to disclose your personal information.
This site has security measures in place to protect the loss, misuse and alteration of the information under our control. For further information regarding our security, please contact us at email@example.com. If you have any concerns regarding the security of information, please do not provide any information to RemedyConnect, Inc. until you are comfortable with our security measures.
You may correct or update your User Registration information at any time, by visiting the User Registration section and providing your personal password that you set at registration. If need be, please email us at firstname.lastname@example.org.
Our site provides users the opportunity to opt-out of receiving e-mail communications from our partners or us, except communications approved by your doctor's practice office. To so opt-out, please email us at email@example.com. To be removed as a user, please email us at the same address. If need be, you may mail requests to us at RemedyConnect, Inc., 9200 E. Mineral Avenue, Suite 100, Centennial, CO 80112. Our telephone number is 303-793-0703.
Contacting the Website
If you have any questions about this privacy statement, the practices of this site, or your dealings with this Website, you can contact us by email at firstname.lastname@example.org or by mail at our address above.